The world's largest maker of generic drugs is about to get even bigger.
Israel's Teva Pharmaceutical (TEVA) is buying Allergan (AGNPRA)'s generic drugs business for $40.5 billion, the company announced Monday.
Teva buys Allergan's generic drugs business for $40.5 billion - Jul. 27, 2015
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.